SRSF2 Gene Mutation
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Patient Response to Immunotherapy Using Spliceosome Mutational Markers (PRISMM) (NCT04447651) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2020-09-17 |
Track SRSF2 Gene Mutation automatically
Every clearance here is in the API, with alerts when new ones post.